Outcomes Mandate National Integration With Cannabis as Medicine

Launched by OMNI MEDICAL SERVICES, LLC · May 8, 2019

Keywords

ClinConnect Summary

This clinical trial, titled "Outcomes Mandate National Integration With Cannabis as Medicine," is studying the effectiveness and safety of medical cannabis for treating a range of chronic medical conditions, such as chronic pain, seizures, and anxiety. The trial is open to adults aged 18 and older who have a qualifying medical condition and can provide informed consent. Participants will need to complete online surveys at the start of the study and at follow-up points to help researchers gather information about their experiences with medical cannabis.

The trial is currently recruiting participants from multiple states, and it is important to note that pregnant or breastfeeding individuals, as well as those with certain mental health issues, will not be eligible to participate. If you decide to join, you will be contributing to valuable research that could help many people who suffer from chronic conditions. Your participation could provide important insights into how medical cannabis may improve quality of life for patients like you.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Clinical diagnosis of a Qualifying Condition for Medical Marijuana
• • Must be 18 years or older unless they have consent from their parent or legal guardian as defined under state law parameters
• • Must be willing to complete online surveys at baseline and the follow up points in this study
• Exclusion Criteria:
• • Pregnancy
• • Breastfeeding
• • Inability to provide informed consent
• • Inability to complete study visits or questionnaires
• • Active suicidality or psychosis, that could be exacerbated by the administration of cannabis